Cargando…
Octaarginine Improves the Efficacy of Nitazoxanide against Cryptosporidium parvum
Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidi...
Autores principales: | Nguyen-Ho-Bao, Tran, Ambe, Lum A., Berberich, Maxi, Hermosilla, Carlos, Taubert, Anja, Daugschies, Arwid, Kamena, Faustin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227457/ https://www.ncbi.nlm.nih.gov/pubmed/35745507 http://dx.doi.org/10.3390/pathogens11060653 |
Ejemplares similares
-
The Oesophageal Squamous Cell Carcinoma Cell Line COLO-680N Fails to Support Sustained Cryptosporidium parvum Proliferation
por: Vélez, Juan, et al.
Publicado: (2021) -
Interplay between Eimeria acervulina and Cryptosporidium parvum during In Vitro Infection of a Chicken Macrophage Cell Line (HD11)
por: Taha, Shahinaz, et al.
Publicado: (2023) -
MCT-Dependent Cryptosporidium parvum-Induced Bovine Monocyte Extracellular Traps (METs) under Physioxia
por: Hasheminasab, Seyed Sajjad, et al.
Publicado: (2023) -
Metabolic Signatures of Cryptosporidium
parvum-Infected HCT-8 Cells and Impact of Selected Metabolic Inhibitors on C. parvum Infection under Physioxia and Hyperoxia
por: Vélez, Juan, et al.
Publicado: (2021) -
First Metabolic Insights into Ex Vivo Cryptosporidium parvum-Infected Bovine Small Intestinal Explants Studied under Physioxic Conditions
por: Vélez, Juan, et al.
Publicado: (2021)